NanoPaz

Technological biomedical fields involved in the program are: women's birth control, contraception technology, intra uterine devices (IUD), Bio-Nano materials, Nano-particles drug delivery, and hormone slow release devices.

New contraception devices are an extensively developing branch of women’s birth control products, supplying very important safer, better and advanced methods and at a moderate cost. The NanoPaz is a new device built on well-known hormone release principles with new Nano materials and an innovated implantation design.

NanoPaz unique know-how and technology is based on IP property (pending) and is in advanced stages of animal model testing and analysis of results. The company plans to start In 2012 early phase clinical trial in Israel.

The company is seeking strategic partners and investors to co-develop and license their projects. Company's goal is to develop the products to the point where it can be marketed to pharmaceutical companies.

About NanoPaz

NanoPaz Pharma Ltd. is a young company specializing in research, development and testing of an innovative treatment and products for advancing Women’s Health. The company leading activity is in the field of advanced contraception NanoPaz Device and Process.

Technology

New contraception devices are an extensively developing branch of women's birth control products supplying safer, better and advanced methods at a moderate cost. NanoPaz is a new device built on well-known hormone release principles with new Nano materials and an innovated implantation design.

Partners & Investors

The company is seeking strategic partners and investors to co-develop and license their projects. Company's goal is to develop the products to the point where it can be marketed to pharmaceutical companies.